Scientists from the University Hospital Würzburg and the Medical University of Vienna have discovered that TREM2, a receptor found on the surface of specific immune cells, could have a significant impact on arteriosclerosis. Their research is aimed at better understanding these mechanisms and developing new treatment methods using a particular antibody.
Originamitteilung:
TREM2, a receptor on the surface of macrophages, could play an important role in atherosclerosis
A publication in Nature Cardiovascular Research from the University Hospital Würzburg (UKW) and the Medical University of Vienna investigates the mechanisms by which the receptor TREM2 affects atherosclerosis and a possible therapeutic approach using an agonistic TREM2 antibody.